Malignant progression

There is 1 paper on malignant progression in aging research: 1 observational study in people. The newest story, Oct 7, 2026: “Blood-cell mutation patterns linked to cancer progression”.

Disease

1 paper studies it41 more mention it2 findings

3 new papers in 30 daysSee all 42

“mutations driving faster clonal growth carry a higher risk of malignant progression”
The longitudinal dynamics and natural history of clonal haematopoiesisNature2022doi:10.1038/s41586-022-04785-z
  • Humans1

Associations

2

Complex karyotype

upin humans1

1 study
  1. Malignant progression is associated with complex karyotype in humans.

    “Malignant progression was accompanied by a complex karyotype, recurrent chromosome 5, 7, and 12p losses enriched in erythroid progenitors”

    Humanserythroid progenitors

    Intense TP53 pathway selection drives clonal evolution from bone marrow failure to leukemia in ERCC6L2 disease

    medRxivPreprint

More on Complex karyotype

Clonal growth rate

upin humans1

1 study
  1. Clonal growth rate is linked with a higher risk of malignant progression in humans (mutations driving faster clonal growth).

    “mutations driving faster clonal growth carry a higher risk of malignant progression”

    Humansmutations driving faster clonal growth

    The longitudinal dynamics and natural history of clonal haematopoiesis

    Nature

More on Clonal growth rate

Latest

Dec 2025: 1Jan 2026: 3Feb 2026: 2Mar 2026: 3Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 2Aug 2026: 3Sep 2026: 3Oct 2026: 3Nov 2026: 021 papers in 12 months
Nucleic Acids Research

Atlas maps sex differences across human cancer cells

The database combines data from 6,764 patient samples, covering 18 cancer types and more than 25.8 million single cells.The database combines data from 6,764 patient samples, covering 18 cancer types and more than 25.8 million single cells.

Computational studyAI & data
HemaSphere

Blood-cell mutation patterns linked to cancer progression

A yearly rise of at least 7.5% in mutated gene copies’ share best predicted cancer progression among patients with unexplained low counts of certain white blood cells.A yearly rise of at least 7.5% in mutated gene copies’ share best predicted cancer progression among patients with unexplained low counts of certain white blood cells.

Cohort study of 256 peopleCancer

See all 42